Crawford Fay, Andras Alina, Welch Karen, Sheares Karen, Keeling David, Chappell Francesca M
NHS Fife, Queen Margaret Hospital, Dunfermline, UK, KY12 0SU.
Cochrane Database Syst Rev. 2016 Aug 5;2016(8):CD010864. doi: 10.1002/14651858.CD010864.pub2.
Pulmonary embolism (PE) can occur when a thrombus (blood clot) travels through the veins and lodges in the arteries of the lungs, producing an obstruction. People who are thought to be at risk include those with cancer, people who have had a recent surgical procedure or have experienced long periods of immobilisation and women who are pregnant. The clinical presentation can vary, but unexplained respiratory symptoms such as difficulty breathing, chest pain and an increased respiratory rate are common.D-dimers are fragments of protein released into the circulation when a blood clot breaks down as a result of normal body processes or with use of prescribed fibrinolytic medication. The D-dimer test is a laboratory assay currently used to rule out the presence of high D-dimer plasma levels and, by association, venous thromboembolism (VTE). D-dimer tests are rapid, simple and inexpensive and can prevent the high costs associated with expensive diagnostic tests.
To investigate the ability of the D-dimer test to rule out a diagnosis of acute PE in patients treated in hospital outpatient and accident and emergency (A&E) settings who have had a pre-test probability (PTP) of PE determined according to a clinical prediction rule (CPR), by estimating the accuracy of the test according to estimates of sensitivity and specificity. The review focuses on those patients who are not already established on anticoagulation at the time of study recruitment.
We searched 13 databases from conception until December 2013. We cross-checked the reference lists of relevant studies.
Two review authors independently applied exclusion criteria to full papers and resolved disagreements by discussion.We included cross-sectional studies of D-dimer in which ventilation/perfusion (V/Q) scintigraphy, computerised tomography pulmonary angiography (CTPA), selective pulmonary angiography and magnetic resonance pulmonary angiography (MRPA) were used as the reference standard.•
Adults who were managed in hospital outpatient and A&E settings and were suspected of acute PE were eligible for inclusion in the review if they had received a pre-test probability score based on a CPR.•
quantitative, semi quantitative and qualitative D-dimer tests.• Target condition: acute symptomatic PE.• Reference standards: We included studies that used pulmonary angiography, V/Q scintigraphy, CTPA and MRPA as reference standard tests.
Two review authors independently extracted data and assessed quality using Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). We resolved disagreements by discussion. Review authors extracted patient-level data when available to populate 2 × 2 contingency tables (true-positives (TPs), true-negatives (TNs), false-positives (FPs) and false-negatives (FNs)).
We included four studies in the review (n = 1585 patients). None of the studies were at high risk of bias in any of the QUADAS-2 domains, but some uncertainty surrounded the validity of studies in some domains for which the risk of bias was uncertain. D-dimer assays demonstrated high sensitivity in all four studies, but with high levels of false-positive results, especially among those over the age of 65 years. Estimates of sensitivity ranged from 80% to 100%, and estimates of specificity from 23% to 63%.
AUTHORS' CONCLUSIONS: A negative D-dimer test is valuable in ruling out PE in patients who present to the A&E setting with a low PTP. Evidence from one study suggests that this test may have less utility in older populations, but no empirical evidence was available to support an increase in the diagnostic threshold of interpretation of D-dimer results for those over the age of 65 years.
当血栓(血凝块)通过静脉流动并阻塞肺部动脉时,可发生肺栓塞(PE)。被认为有风险的人群包括癌症患者、近期接受过外科手术或长期制动的人以及孕妇。临床表现可能各不相同,但呼吸困难、胸痛和呼吸频率增加等不明原因的呼吸道症状很常见。D - 二聚体是当血凝块因正常身体过程或使用规定的纤维蛋白溶解药物而分解时释放到循环系统中的蛋白质片段。D - 二聚体检测是一种实验室检测方法,目前用于排除高D - 二聚体血浆水平的存在,并由此排除静脉血栓栓塞(VTE)。D - 二聚体检测快速、简单且成本低廉,可避免与昂贵诊断检测相关的高成本。
通过根据敏感性和特异性估计值评估检测的准确性,研究在医院门诊和急诊(A&E)环境中接受治疗、根据临床预测规则(CPR)确定了肺栓塞预测试概率(PTP)的患者中,D - 二聚体检测排除急性肺栓塞诊断的能力。本综述重点关注在研究招募时尚未接受抗凝治疗的患者。
我们从数据库建立至2013年12月检索了13个数据库。我们交叉核对了相关研究的参考文献列表。
两位综述作者独立对全文应用排除标准,并通过讨论解决分歧。我们纳入了将通气/灌注(V/Q)闪烁扫描、计算机断层扫描肺动脉造影(CTPA)、选择性肺动脉造影和磁共振肺动脉造影(MRPA)用作参考标准的D - 二聚体横断面研究。
在医院门诊和急诊环境中接受治疗且疑似急性肺栓塞的成年人,如果他们根据CPR获得了预测试概率评分,则有资格纳入本综述。
定量、半定量和定性D - 二聚体检测。
急性症状性肺栓塞。
我们纳入了使用肺动脉造影、V/Q闪烁扫描、CTPA和MRPA作为参考标准检测的研究。
两位综述作者独立提取数据,并使用诊断准确性研究质量评估 - 2(QUADAS - 2)评估质量。我们通过讨论解决分歧。综述作者在可行时提取患者水平的数据,以填充2×2列联表(真阳性(TP)、真阴性(TN)、假阳性(FP)和假阴性(FN))。
我们在综述中纳入了四项研究(n = 1585例患者)。在QUADAS - 2的任何领域中,没有一项研究存在高偏倚风险,但在一些偏倚风险不确定的领域,研究的有效性存在一些不确定性。D - 二聚体检测在所有四项研究中均显示出高敏感性,但假阳性结果水平较高,尤其是在65岁以上人群中。敏感性估计值范围为80%至100%,特异性估计值范围为23%至63%。
D - 二聚体检测结果为阴性对于排除PTP较低且前往急诊就诊的患者的肺栓塞很有价值。一项研究的证据表明,该检测在老年人群中的效用可能较低,但没有实证证据支持提高65岁以上人群D - 二聚体检测结果解读的诊断阈值。